At the 37th Annual News and Documentary Emmy® Awards, PBS was awarded an Outstanding Science and Technology Programming Emmy for "TWICE BORN: Stories from The Special Delivery Unit," featuring Children's Hospital of Philadelphia.

Just as prenatal imaging is imperative to establishing the diagnosis of fetal neck mass, genetic testing can be crucial to determining prognosis, availability of fetal interventions and recurrence risk for a family.

The treatment of lymphatic malformations is complex and requires a multidisciplinary team, including pediatric interventional radiology. At CHOP, there are two pediatric interventional radiologists with a special interest in treating vascular malformations.

Congenital neck masses are now more often detected in utero due to high-resolution ultrasounds and fetal MRIs, which help differentiate the various types of neck masses.

Newborns with a neck mass are cared for in CHOP's N/IICU by the Neonatal Surgical Team. Sclerotherapy is one of the treatment method used in babies with lymphatic malformations.

Although rare, two of the most common congenital neck masses diagnosed during pregnancy are cervical teratomas and cervical lymphatic malformations. Learn about the delivery and treatment options of neck masses.

An in-depth look at the comprehensive care available for neck masses, complex conditions with the potential to grow large and block the fetal airway.

The Pulmonary Hypoplasia Program at The Children’s Hospital of Philadelphia is committed to tracking outcomes of children with pulmonary hypoplasia in an effort to improve understanding and care. A recent review of neurodevelopmental outcomes at 5 years of age found that CDH survivors are at increased risk for developing emotionally reactive and pervasive developmental problems.

Neonates with congenital diaphragmatic hernia (CDH) often require intensive treatment after birth and have prolonged hospitalizations, and may suffer a variety of complications after discharge. Comprehensive interdisciplinary follow-up care is critical for long-term well being.

Despite advances in care, there remain high rates of morbidity and mortality in cases of severe CDH. Read about CHOP’s FDA-approved study of fetoscopic endoluminal tracheal occlusion (FETO).